Physician profile
Brad A Prather
NPI 1952445710
$5,703.32
in general payments reported to CMS, 2019-2025
8 companies · $2,347 in 2025
The $2,347 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $53.85 · 2021: $889 · 2023: $23.33 · 2024: $2,115 · 2025: $2,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,884 · Food and Beverage: $1,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,884.23 |
| Food and Beverage | $1,601.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,272.48 | 2019-2025 | Journey II, Journey, Ri Hip Navigation |
| Medtronic USA, INC. | $161.86 | 2019 | |
| Ferring Pharmaceuticals INC. | $119.75 | 2020-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $55.23 | 2025 | |
| Djo, LLC | $42.29 | 2023-2024 | Donjoy, Cmf |
| Depuy Synthes Sales INC. | $20.83 | 2020 | |
| Zimmer Biomet Holdings, INC. | $15.90 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $14.98 | 2025 | Vibativ |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Prather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.